Andre Choulika
Co-Founder, CEO & DirectorDr. Andre Choulika, Ph.D. is the Founder of Cellectis S.A. and has been its Chief Executive Officer since 1999 and served as its Chairman since 2011 until November 5, 2020. He is the Director of Cellectis S.A. since 1999. Dr. Choulika is a pioneer in the analysis and use of Meganucleases to modify complex genomes. Dr. Choulika has made many of the critical observations in the field and is an author of the most significant patents on the use of Meganucleases in vivo. He served as Chairman of Calyxt, Inc. since August 2010 until July 6, 2020. He is CEO and Chairman of Cellectis, Inc. since December 2014 and Cellectis Biologics, Inc. since January 2019. He serves as the Chairman of France Biotech. He is Director of Cellectis S.A. He served as President of Calyxt, Inc. since August 2010. From 1997 to 1999, Dr. Choulika worked as a post-doctoral fellow in the Division of Molecular Medicine at Boston Children’s Hospital, where he was one of the inventors of nuclease-based genome editing technologies and a pioneer in the analysis and use of meganucleases to modify complex genomes. After receiving his Ph.D. in molecular virology from the University of Paris VI (Pierre et Marie Curie), he completed a research fellowship in the Harvard Medical School Department of Genetics. His management training is from the HEC (Challenge +). Since June 2019, Dr. Choulika served at the board of directors of Institut Pasteur. Dr. Choulika was awarded Chevalier of the Légion d’Honneur in France.
公司职务
- 公司名称Cellectis S.A.股票代码CLLS职务Co-Founder, CEO & Director共事同僚
- JGJean-Pierre GarnierIndependent Non-Executive Chairman
- DJDavid J. SourdiveCo-Founder, Deputy CEO, Executive VP of CMC & Manufacturing and Director
- ASArthur StrilCFO & Chief Business Officer
- VCValerie CrosPrincipal Financial Officer & Principal Accounting Officer
- JCJean Charles EpinatChief Technological Officer
- ACAndre C. MullerIndependent Director
- LALaurent ArthaudDirector
